Featured Research

from universities, journals, and other organizations

Common Antibiotics May Be Best First Treatment For Children With MRSA-related Infections

Date:
May 29, 2009
Source:
Agency for Healthcare Research and Quality
Summary:
Penicillin and other antibiotics in the beta-lactam family work as well as other antibiotics to treat MRSA (methicillin-resistant Staphylococcuss aureus) infections in the skin and soft-tissue of children and may help prevent further resistance to antibiotic treatment, according to a new study.

Penicillin and other antibiotics in the beta-lactam family work as well as other antibiotics to treat MRSA (methicillin-resistant Staphylococcuss aureus) infections in the skin and soft-tissue of children and may help prevent further resistance to antibiotic treatment, according to a new study.

Related Articles


The study, published in the June, 2009 issue of Pediatrics, compared treatment outcomes for three different antibiotics – beta-lactums (which include penicillin, cephalosporins, carbapenems and monobactams), clindamycin, and trimethoprim-sulfamethoxazole. The study concluded that children treated with clindamycin for skin and soft tissue infections potentially caused by MRSA did not show greater improvement compared to those treated with beta-lactam therapy. Children treated with trimethoprim-sulfamethoxazole were less likely to show improvement.

Among the study’s findings:

  • Beta- lactams may still be the best first line initial therapy for skin and soft tissue infections possibly caused by MRSA.
  • Community- Acquired MRSA may not be the cause of skin and soft tissue infections even when MRSA is prevalent.
  • The use of beta-lactams may help prevent further resistance to antibiotic treatment of skin and tissue infections.
  • Beta-lactam therapy is more palatable to children than clindamycin because it is not associated with side effects, such as nausea and mild diarrhea. It is also not as expensive as other treatments.

The authors of this study recommend further research to establish a higher level of evidence and to confirm study results.

This study was funded by a cooperative agreement through an Agency for Healthcare Research and Quality grant to the Centers for Education and Research on Therapeutics (CERTs) research network, which is part of the agency's Effective Health Care Program.


Story Source:

The above story is based on materials provided by Agency for Healthcare Research and Quality. Note: Materials may be edited for content and length.


Cite This Page:

Agency for Healthcare Research and Quality. "Common Antibiotics May Be Best First Treatment For Children With MRSA-related Infections." ScienceDaily. ScienceDaily, 29 May 2009. <www.sciencedaily.com/releases/2009/05/090527180558.htm>.
Agency for Healthcare Research and Quality. (2009, May 29). Common Antibiotics May Be Best First Treatment For Children With MRSA-related Infections. ScienceDaily. Retrieved March 5, 2015 from www.sciencedaily.com/releases/2009/05/090527180558.htm
Agency for Healthcare Research and Quality. "Common Antibiotics May Be Best First Treatment For Children With MRSA-related Infections." ScienceDaily. www.sciencedaily.com/releases/2009/05/090527180558.htm (accessed March 5, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, March 5, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Bupa Eyes India Healthcare Opportunities

Bupa Eyes India Healthcare Opportunities

Reuters - Business Video Online (Mar. 5, 2015) Bupa is hoping to expand in India&apos;s fast-growing health insurance market, once a rule change on foreign investment is implemented. The British private healthcare group&apos;s CEO tells Grace Pascoe why it&apos;s so keen on the new opportunity. Video provided by Reuters
Powered by NewsLook.com
Doctor in Your Pocket Is Getting Smarter

Doctor in Your Pocket Is Getting Smarter

Reuters - Business Video Online (Mar. 5, 2015) Mobile apps are turning smartphones into a personal doctors, with users able to measure heart rate, blood pressure and even blood sugar. But will it change our behaviour? Ivor Bennett reports from the Mobile World Congress in Barcelona. Video provided by Reuters
Powered by NewsLook.com
AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

Newsy (Mar. 5, 2015) AbbVie announced Wednesday it will buy cancer drugmaker Pharmacyclics in a $21 billion deal. Video provided by Newsy
Powered by NewsLook.com
Toddlers Drinking Coffee? Why You Shouldn't Share Your Joe

Toddlers Drinking Coffee? Why You Shouldn't Share Your Joe

Newsy (Mar. 5, 2015) A survey of Boston mothers and toddlers found that 15 percent of two-year-olds drink coffee and 2.5 percent of 1-year-olds. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins